Therefore, strategies to specifically target NOTCH3 signalling provide an attractive therapeutic option to treat and control lung disease pathogenesis (Refs 59, 60, 61, 62, 63, 64, 65, 68, 136). Here, NOTCH3 is linked to lung disorder.